RECODE · 연구동향생성일 2026-10-31

연구동향

기준 논문: Topographic patterns of brain functional impairment progression according to clinical severity staging in 116 Alzheimer disease patients: FDG-PET study

Alzheimer Dis Assoc Disord 21(2):77-84 · 2007 · PMID 17545731

검색 방법

이 논문의 제목과 주제어를 바탕으로 이 논문이 속한 연구 분야를 묻는 질문을 만들어 ReviewFast에 넣어 2026-10-31에 검색했습니다. ReviewFast가 PubMed를 검색하고, AI 모델(Jev)이 제목과 초록을 읽어 질문과의 관련도를 매긴 뒤 주제별로 묶었습니다.

322편 검색→313편 판독→93편 선별 (관련도 0.5 이상)

질문과 PubMed 검색식 보기질문: Topographic progression of cerebral glucose hypometabolism on FDG-PET across Alzheimer disease severity (("Alzheimer disease"[tiab] OR "Alzheimer's disease"[tiab] OR Alzheimer[tiab] OR "mild cognitive impairment"[tiab]) AND ("fluorodeoxyglucose"[tiab] OR FDG[tiab] OR "FDG-PET"[tiab] OR "glucose metabolism"[tiab] OR hypometabolism[tiab]) AND (progression[tiab] OR severity[tiab] OR staging[tiab] OR "disease stage"[tiab]) AND (topograph*[tiab] OR spatial[tiab] OR regional[tiab] OR distribution[tiab]))

출판 연도

1986: 1편119861987: 1편11988: 1편119901991: 1편11994: 2편21995: 1편119951996: 2편21997: 1편11998: 3편31999: 3편32000: 1편120002001: 2편22002: 4편42004: 2편220052007: 2편22008: 2편22009: 1편12010: 2편220102011: 2편22012: 2편22013: 2편22014: 1편12015: 3편320152016: 4편42017: 2편22018: 10편102019: 2편22020: 5편520202021: 3편32022: 3편32023: 7편72024: 8편82025: 3편32026: 4편42026

선별된 93편의 출판 연도. 검색일(2026-10-31) 기준이며, 그 이후 논문은 들어 있지 않습니다.

주제별 논문

주제 이름은 ReviewFast가 초록의 단어로 자동으로 붙인 것입니다. 왼쪽 숫자는 관련도(0–1)입니다. RECODE 는 우리 연구팀 논문입니다.

01network · cognitive decline19편

  1. 0.84

    Progressive Disintegration of Brain Networking from Normal Aging to Alzheimer Disease: Analysis of Independent Components of (18)F-FDG PET Data

    Pagani M, Giuliani A, Oberg J et al. · Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2017

  2. 0.83

    Longitudinal progression of cognitive decline correlates with changes in the spatial pattern of brain 18F-FDG PET

    Shokouhi S, Claassen D, Kang H et al. · Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2013

  3. 0.77

    Characteristic patterns of inter- and intra-hemispheric metabolic connectivity in patients with stable and progressive mild cognitive impairment and Alzheimer's disease

    Huang SY, Hsu JL, Lin KJ et al. · Scientific reports · 2018

  4. 0.77

    Data-driven models of dominantly-inherited Alzheimer's disease progression

    Oxtoby NP, Young AL, Cash DM et al. · Brain : a journal of neurology · 2018

  5. 0.76

    Distinct relationships of amyloid-beta and tau deposition to cerebral glucose metabolic networks in Alzheimer's disease

    Sun X, Nie B, Zhao S et al. · Neuroscience letters · 2020

  6. 0.76

    Anosognosia predicts default mode network hypometabolism and clinical progression to dementia

    Therriault J, Ng KP, Pascoal TA et al. · Neurology · 2018

  7. 0.75

    Simultaneous PET/fMRI Detects Distinctive Alterations in Functional Connectivity and Glucose Metabolism of Precuneus Subregions in Alzheimer's Disease

    Zhang M, Sun W, Guan Z et al. · Frontiers in aging neuroscience · 2021

  8. 0.75

    Multiscale Metabolic Covariance Networks Uncover Stage-Specific Biomarker Signatures Across the Alzheimer's Disease Continuum

    Chong Chie JAK, Persohn SA, Pandey RS et al. · bioRxiv : the preprint server for biology · 2025

  9. 0.72

    Spatial patterns of atrophy, hypometabolism, and amyloid deposition in Alzheimer's disease correspond to dissociable functional brain networks

    Grothe MJ, Teipel SJ · Human brain mapping · 2016

  10. 0.71

    Multidomain Analysis of Clinical Cognitive Assessments and Imaging Data in Alzheimer's Disease Accurately Predicts Disease Stage and Grade Independent of Amyloid and Tau

    Chong Chie JAKH, Persohn SA, Simcox OR et al. · bioRxiv : the preprint server for biology · 2026

  11. 0.68

    A causal deep learning approach to identifying metabolic signatures of cognitive and functional decline in alzheimer's disease

    Priyadarshini B, Alex JSR · Scientific reports · 2026

  12. 0.67

    Abeta-induced vulnerability propagates via the brain's default mode network

    Pascoal TA, Mathotaarachchi S, Kang MS et al. · Nature communications · 2019

  13. 0.66

    Contribution of local amyloid-beta and tau burden to hypometabolism in autosomal-dominant Alzheimer's disease

    Tristao-Pereira C, Langella S, Baena A et al. · Brain communications · 2026

  14. 0.66

    Neuropsychiatric symptoms are early indicators of an upcoming metabolic decline in Alzheimer's disease

    Ng KP, Pascoal TA, Mathotaarachchi S et al. · Translational neurodegeneration · 2021

  15. 0.64

    Semantic loss marks early Alzheimer's disease-related neurodegeneration in older adults without dementia

    Vonk JMJ, Bouteloup V, Mangin JF et al. · Alzheimer's & dementia (Amsterdam, Netherlands) · 2020

  16. 0.63

    Regional changes in brain metabolism during the progression of mild cognitive impairment: a longitudinal study based on radiomics

    Mu X, Cui C, Liao J et al. · EJNMMI reports · 2024

  17. 0.51

    Lost in space(s): Multimodal neuroimaging of disorientation along the Alzheimer's disease continuum

    Peters-Founshtein G, Gazit L, Naveh T et al. · Human brain mapping · 2024

  18. 0.51

    Regional 18F-Fluorodeoxyglucose Hypometabolism is Associated with Higher Apathy Scores Over Time in Early Alzheimer Disease

    Gatchel JR, Donovan NJ, Locascio JJ et al. · The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry · 2017

  19. 0.50

    Regional vulnerability in Alzheimer's disease: The role of cell-autonomous and transneuronal processes

    Acosta D, Powell F, Zhao Y et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2018

02amyloid · uptake17편

  1. 0.91

    Accelerated hypometabolism with disease progression associated with faster cognitive decline among amyloid positive patients

    Yang Z, Cummings JL, Kinney JW et al. · Frontiers in neuroscience · 2023

  2. 0.84

    Left lateralized cerebral glucose metabolism declines in amyloid-beta positive persons with mild cognitive impairment

    Weise CM, Chen K, Chen Y et al. · NeuroImage. Clinical · 2018

  3. 0.83

    Role of beta-Amyloidosis and Neurodegeneration in Subsequent Imaging Changes in Mild Cognitive Impairment

    Knopman DS, Jack CRJ, Lundt ES et al. · JAMA neurology · 2015

  4. 0.83

    Evolution of neurodegeneration-imaging biomarkers from clinically normal to dementia in the Alzheimer disease spectrum

    Knopman DS, Jack CRJ, Lundt ES et al. · Neurobiology of aging · 2016

  5. 0.82

    Time course of glucose metabolism in relation to cognitive performance and postmortem neuropathology in Met146Val PSEN1 mutation carriers

    Scholl M, Almkvist O, Bogdanovic N et al. · Journal of Alzheimer's disease : JAD · 2011

  6. 0.79

    Longitudinal imaging of Alzheimer pathology using [11C]PIB, [18F]FDDNP and [18F]FDG PET

    Ossenkoppele R, Tolboom N, Foster-Dingley JC et al. · European journal of nuclear medicine and molecular imaging · 2012

  7. 0.78

    Dynamic changes in PET amyloid and FDG imaging at different stages of Alzheimer's disease

    Kadir A, Almkvist O, Forsberg A et al. · Neurobiology of aging · 2012

  8. 0.74

    Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer's disease

    Rodriguez-Vieitez E, Saint-Aubert L, Carter SF et al. · Brain : a journal of neurology · 2016

  9. 0.71

    Increased metabolic vulnerability in early-onset Alzheimer's disease is not related to amyloid burden

    Rabinovici GD, Furst AJ, Alkalay A et al. · Brain : a journal of neurology · 2010

  10. 0.69

    Longitudinal uncoupling of cerebral perfusion, glucose metabolism, and tau deposition in Alzheimer's disease

    Leuzy A, Rodriguez-Vieitez E, Saint-Aubert L et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2018

  11. 0.66

    Positron emission tomography imaging and clinical progression in relation to molecular pathology in the first Pittsburgh Compound B positron emission tomography patient with Alzheimer's disease

    Kadir A, Marutle A, Gonzalez D et al. · Brain : a journal of neurology · 2011

  12. 0.66

    Longitudinal influence of microglial activation and amyloid on neuronal function in Alzheimer's disease

    Fan Z, Okello AA, Brooks DJ et al. · Brain : a journal of neurology · 2015

  13. 0.65

    Longitudinal changes of tau PET imaging in relation to hypometabolism in prodromal and Alzheimer's disease dementia

    Chiotis K, Saint-Aubert L, Rodriguez-Vieitez E et al. · Molecular psychiatry · 2018

  14. 0.59

    Imaging correlations of tau, amyloid, metabolism, and atrophy in typical and atypical Alzheimer's disease

    Whitwell JL, Graff-Radford J, Tosakulwong N et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2018

  15. 0.56

    The combined effects of microglia activation and brain glucose hypometabolism in early-onset Alzheimer's disease

    Tondo G, Iaccarino L, Caminiti SP et al. · Alzheimer's research & therapy · 2020

  16. 0.56

    Do Tau Deposition and Glucose Metabolism Dissociate in Alzheimer's Disease Trajectory?

    Nowell J, Raza S, Livingston NR et al. · Journal of Alzheimer's disease : JAD · 2024

  17. 0.51

    Amyloid and tau imaging, neuronal losses and function in mild cognitive impairment

    Barrio JR, Kepe V, Satyamurthy N et al. · The journal of nutrition, health & aging · 2008

03areas · metabolic17편

  1. 0.88

    Clinical deterioration in probable Alzheimer's disease correlates with progressive metabolic impairment of association areas

    Mielke R, Herholz K, Grond M et al. · Dementia (Basel, Switzerland) · 1994

  2. 0.84

    Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease

    Minoshima S, Giordani B, Berent S et al. · Annals of neurology · 1997

  3. 0.82

    Positron emission tomography in patients with clinically diagnosed Alzheimer's disease

    McGeer PL, Kamo H, Harrop R et al. · CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 1986

  4. 0.81

    Different Scales of Cortical Organization are Selectively Targeted in the Progression to Alzheimer's Disease

    Romero-Garcia R, Atienza M, Cantero JL · International journal of neural systems · 2016

  5. 0.81

    Topographical analysis of glucose metabolism, as measured with positron emission tomography, in dementia of the Alzheimer type: use of linear histograms

    McNamara D, Horwitz B, Grady CL et al. · The International journal of neuroscience · 1987

  6. 0.80

    Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET

    Herholz K, Salmon E, Perani D et al. · NeuroImage · 2002

  7. 0.73

    Association between brain functional failure and dementia severity in Alzheimer's disease: resting versus stimulation PET study

    Pietrini P, Furey ML, Alexander GE et al. · The American journal of psychiatry · 1999

  8. 0.73

    Relationships between amyloid levels, glucose metabolism, morphologic changes in the brain and clinical status of patients with Alzheimer's disease

    Thientunyakit T, Sethanandha C, Muangpaisan W et al. · Annals of nuclear medicine · 2020

  9. 0.70

    Cerebral metabolic response to passive audiovisual stimulation in patients with Alzheimer's disease and healthy volunteers assessed by PET

    Pietrini P, Alexander GE, Furey ML et al. · Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2000

  10. 0.67

    Difference of regional cerebral metabolic pattern between presenile and senile dementia of the Alzheimer type: a factor analytic study

    Ichimiya A, Herholz K, Mielke R et al. · Journal of the neurological sciences · 1994

  11. 0.65

    Age at onset and regional cerebral glucose metabolism in Alzheimer's disease

    Yasuno F, Imamura T, Hirono N et al. · Dementia and geriatric cognitive disorders · 1998

  12. 0.60

    Combined study of cerebral glucose metabolism and [11C]methionine accumulation in probable Alzheimer's disease using positron emission tomography

    Salmon E, Gregoire MC, Delfiore G et al. · Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 1996

  13. 0.59

    The role of emission tomography in dementia

    Perani D · Italian journal of neurological sciences · 1999

  14. 0.59

    Neuropsychological function and cerebral glucose utilization in isolated memory impairment and Alzheimer's disease

    Berent S, Giordani B, Foster N et al. · Journal of psychiatric research · 1999

  15. 0.58

    Impaired metabolic activation in Alzheimer's disease: a PET study during continuous visual recognition

    Kessler J, Herholz K, Grond M et al. · Neuropsychologia · 1991

  16. 0.57

    Cognitive impairment in Alzheimer's disease correlates with ventricular width and atrophy-corrected cortical glucose metabolism

    Slansky I, Herholz K, Pietrzyk U et al. · Neuroradiology · 1995

  17. 0.57

    Apolipoprotein E polymorphism influences the cerebral metabolic pattern in Alzheimer's disease

    Mielke R, Zerres K, Uhlhaas S et al. · Neuroscience letters · 1998

04left · right15편

  1. 0.96

    Topographic patterns of brain functional impairment progression according to clinical severity staging in 116 Alzheimer disease patients: FDG-PET study 이 논문

    Choo IH, Lee DY, Youn JC et al. · Alzheimer disease and associated disorders · 2007

  2. 0.86

    The neural substrates of episodic memory impairment in Alzheimer's disease as revealed by FDG-PET: relationship to degree of deterioration

    Desgranges B, Baron JC, Lalevee C et al. · Brain : a journal of neurology · 2002

  3. 0.86

    One-year change in cerebral glucose metabolism in patients with Alzheimer's disease

    Hirono N, Hashimoto M, Ishii K et al. · The Journal of neuropsychiatry and clinical neurosciences · 2004

  4. 0.80

    Heterogeneous anterior-posterior metabolic patterns in dementia of the Alzheimer type

    Haxby JV, Grady CL, Koss E et al. · Neurology · 1988

  5. 0.80

    Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer's Disease Neuroimaging Initiative (ADNI)

    Langbaum JBS, Chen K, Lee W et al. · NeuroImage · 2009

  6. 0.79

    Dynamic Amyloid and Metabolic Signatures of Delayed Recall Performance within the Clinical Spectrum of Alzheimer's Disease

    Tedeschi Dauar M, Pascoal TA, Therriault J et al. · Brain sciences · 2023

  7. 0.77

    Cerebral metabolic correlates of the clinical dementia rating scale in mild cognitive impairment

    Perneczky R, Hartmann J, Grimmer T et al. · Journal of geriatric psychiatry and neurology · 2007

  8. 0.75

    Metabolic correlates of reserve and resilience in MCI due to Alzheimer's Disease (AD)

    Bauckneht M, Chincarini A, Piva R et al. · Alzheimer's research & therapy · 2018

  9. 0.69

    Functional Neural Correlates of Semantic Fluency Task Performance in Mild Cognitive Impairment and Alzheimer's Disease: An FDG-PET Study

    Ahn H, Yi D, Chu K et al. · Journal of Alzheimer's disease : JAD · 2022

  10. 0.67

    Relationship between both IQ and Mini-Mental State Examination and the regional cerebral glucose metabolism in clinically diagnosed Alzheimer's disease: a PET study

    Kawano M, Ichimiya A, Ogomori K et al. · Dementia and geriatric cognitive disorders · 2001

  11. 0.60

    Distinct Neural Correlates of Executive Function by Amyloid Positivity and Associations with Clinical Progression in Mild Cognitive Impairment

    Yoon HJ, Kim SG, Kim SH et al. · Yonsei medical journal · 2019

  12. 0.58

    Reduced FDG-PET brain metabolism and executive function predict clinical progression in elderly healthy subjects

    Ewers M, Brendel M, Rizk-Jackson A et al. · NeuroImage. Clinical · 2014

  13. 0.53

    Phenotype-specific metabolic patterns in Posterior cortical atrophy and early-onset typical Alzheimer's disease

    Lu J, Chen K, Lin H et al. · Annals of nuclear medicine · 2025

  14. 0.51

    Hypofunction in the posterior cingulate gyrus correlates with disorientation for time and place in Alzheimer's disease

    Hirono N, Mori E, Ishii K et al. · Journal of neurology, neurosurgery, and psychiatry · 1998

  15. 0.50

    Regional cerebral THK5351 accumulations correlate with neuropsychological test scores in Alzheimer continuum

    Im S, Hanaoka K, Yamada T et al. · Asia Oceania journal of nuclear medicine & biology · 2023

05diagnosis · lewy12편

  1. 0.86

    Generative FDG-PET and MRI model of aging and disease progression in Alzheimer's disease

    Dukart J, Kherif F, Mueller K et al. · PLoS computational biology · 2013

  2. 0.75

    The Association Between Brain Metabolic Biomarkers Using (18)F-FDG and Cognition and Vascular Risk Factors, as well as Its Usefulness in the Diagnosis and Staging of Alzheimer's Disease

    Xiong M, You H, Liao W et al. · Journal of Alzheimer's disease reports · 2024

  3. 0.70

    Data-driven FDG-PET subtypes of Alzheimer's disease-related neurodegeneration

    Levin F, Ferreira D, Lange C et al. · Alzheimer's research & therapy · 2021

  4. 0.70

    Phenotypic subtypes of progressive dysexecutive syndrome due to Alzheimer's disease: a series of clinical cases

    Corriveau-Lecavalier N, Machulda MM, Botha H et al. · Journal of neurology · 2022

  5. 0.69

    Brain metabolic signatures across the Alzheimer's disease spectrum

    Sala A, Caprioglio C, Santangelo R et al. · European journal of nuclear medicine and molecular imaging · 2020

  6. 0.65

    Deciphering the clinico-radiological heterogeneity of dysexecutive Alzheimer's disease

    Corriveau-Lecavalier N, Barnard LR, Lee J et al. · Cerebral cortex (New York, N.Y. : 1991) · 2023

  7. 0.62

    Geometric brain signatures of Alzheimer's disease progression and subtypes

    Tong B, Cao T, Duong-Tran D et al. · medRxiv : the preprint server for health sciences · 2026

  8. 0.58

    Baseline multimodal imaging to predict longitudinal clinical decline in atypical Alzheimer's disease

    Coburn RP, Graff-Radford J, Machulda MM et al. · Cortex; a journal devoted to the study of the nervous system and behavior · 2024

  9. 0.56

    Divergent neurodegenerative patterns: Comparison of [(18)F] fluorodeoxyglucose-PET- and MRI-based Alzheimer's disease subtypes

    Wheatley SH, Mohanty R, Poulakis K et al. · Brain communications · 2024

  10. 0.55

    Brain metabolic maps in Mild Cognitive Impairment predict heterogeneity of progression to dementia

    Cerami C, Della Rosa PA, Magnani G et al. · NeuroImage. Clinical · 2015

  11. 0.51

    Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome

    Silverman DH, Small GW, Chang CY et al. · JAMA · 2001

  12. 0.51

    Distinct subtypes of spatial brain metabolism patterns in Alzheimer's disease identified by deep learning-based FDG PET clusters

    Ryoo HG, Choi H, Shi K et al. · European journal of nuclear medicine and molecular imaging · 2024

06magnetic resonance · mri6편

  1. 0.84

    Patterns of Glucose Metabolism in [ (18) F]FDG PET Indicate Regional Variability and Neurodegeneration in the Progression of Alzheimer's Dementia

    Lee JJ, Earnest T, Ha SM et al. · medRxiv : the preprint server for health sciences · 2023

  2. 0.74

    Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies

    Alexander GE, Chen K, Pietrini P et al. · The American journal of psychiatry · 2002

  3. 0.67

    Neuroimaging analyses from a randomized, controlled study to evaluate plasma exchange with albumin replacement in mild-to-moderate Alzheimer's disease: additional results from the AMBAR study

    Cuberas-Borros G, Roca I, Castell-Conesa J et al. · European journal of nuclear medicine and molecular imaging · 2022

  4. 0.59

    In vivo imaging of region and cell type specific neocortical neurodegeneration in Alzheimer's disease. Perspectives of MRI derived corpus callosum measurement for mapping disease progression and effects of therapy. Evidence from studies with MRI, EEG and PET

    Hampel H, Teipel SJ, Alexander GE et al. · Journal of neural transmission (Vienna, Austria : 1996) · 2002

  5. 0.57

    Cerebral glucose metabolism in preclinical and prodromal Alzheimer's disease

    Herholz K · Expert review of neurotherapeutics · 2010

  6. 0.55

    Predicting Imminent Progression to Clinically Significant Memory Decline Using Volumetric MRI and FDG PET

    Stonnington CM, Chen Y, Savage CR et al. · Journal of Alzheimer's disease : JAD · 2018

07csf · cerebrospinal fluid6편

  1. 0.71

    Mapping cerebral atrophy and hypometabolism on (18)F-FDG PET/CT scans for detecting Alzheimer's disease in the Malaysian population using a Malaysian brain atlas template

    Siti Aishah AA, Normala I, Faruque Reza M et al. · The Medical journal of Malaysia · 2023

  2. 0.68

    CSF total and phosphorylated tau protein, regional glucose metabolism and dementia severity in Alzheimer's disease

    Haense C, Buerger K, Kalbe E et al. · European journal of neurology · 2008

  3. 0.62

    Cerebrospinal fluid NPTX2 changes and relationship with regional brain metabolism metrics across mild cognitive impairment due to Alzheimer's disease

    Massa F, Martinuzzo C, Gomez de San Jose N et al. · Journal of neurology · 2024

  4. 0.62

    Brain metabolic decreases related to the dose of the ApoE e4 allele in Alzheimer's disease

    Mosconi L, Nacmias B, Sorbi S et al. · Journal of neurology, neurosurgery, and psychiatry · 2004

  5. 0.56

    Cerebrospinal fluid NPTX2 and [(18)F]FDG PET track serotonergic vulnerability to neurodegeneration in prodromal Alzheimer's disease

    Massa F, Orso B, De Cesari F et al. · Alzheimer's research & therapy · 2025

  6. 0.51

    A biomarker-validated time scale in years of disease progression has identified early- and late-onset subgroups in sporadic Alzheimer's disease

    Almkvist O, Nordberg A · Alzheimer's research & therapy · 2023

08mice · model1편

  1. 0.58

    Evidence for physiological down-regulation of brain oxidative phosphorylation in Alzheimer's disease

    Chandrasekaran K, Hatanpaa K, Brady DR et al. · Experimental neurology · 1996